This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Pediatrics  • Adolescent Medicine  • Psychiatry  • Depression  • Drug Therapy  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Bridget M. Kuehn

JAMA. 2009;301(20):2085.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The US Preventive Services Task Force (USPSTF) recommends screening adolescents aged 12 through 18 years for depression, but only when systems are in place to ensure proper diagnosis and to provide psychotherapy and follow-up care. The task force also concluded there were insufficient data to recommend such screening for children.

The US Preventive Services Task Force recommends screening adolescents for depression, but only when appropriate mental health services are available. (Photo credit: David Grossman/www.sciencesource.com)

Since 2002, when the USPSTF had determined that there was not enough evidence to recommend for or against depression screening for adolescents or children, new evidence has emerged suggesting that adolescents with major depressive disorder may benefit from treatment. Such treatment, according to the task force, includes selective serotonin reuptake inhibitors (only fluoxetine is approved for use in adolescents), a variety of psychotherapeutic techniques, and therapy combining such medication and behavioral . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?